Amiodarone, a benzofuranic iodine-rich pan-anti-arrhythmic drug, induces amiodarone-
induced thyrotoxicosis (AIT) in 7–15% of patients. AIT is a major issue due to its typical …

Amiodarone-induced thyrotoxicosis (AIT) is a clinical condition fraught with difficulties and
uncertainties both from the diagnostic and therapeutic standpoints (1). Diagnosis and …

Amiodarone is one of the most commonly prescribed antiarrhythmic agents in clinical
practice owing to its efficacy, even with high toxicity profile. The high iodine content and the …

Amiodarone, a benzofuranic iodine-rich antiarrhythmic drug, causes thyroid dysfunction in
15–20% of cases. Although amiodarone-induced hypothyroidism poses no particular …

Amiodarone is used increasingly in a number of cardiac conditions. Amiodarone is heavily
iodinated and can cause thyroid dysfunction. The diagnosis of amiodarone-induced …

The incidence of type 2 amiodarone-induced thyrotoxicosis (AIT) is increasing. A new study
provides evidence that glucocorticoid therapy is safe, effective and associated with prompt …

Amiodarone, a benzofuranic iodine-rich pan antiarrhythmic drug, is frequently associated
with thyroid dysfunction. This side effect is heterogeneous and unpredicted, motivating …

Amiodarone-induced thyroid dysfunction occurs in 15–20% of amiodarone-treated patients.
Amiodarone-induced hypothyroidism (AIH) does not pose relevant problems, is easily …

Amiodarone (AM), a potent class III anti-arrhythmic drug, is an iodine-rich compound with a
structural resemblance to thyroid hormones triiodothyronine (T3) and thyroxine (T4). At the …

Summary objective To determine how expert European thyroidologists assess and treat
amiodarone‐induced thyrotoxicosis (AIT). design Members of the European Thyroid …